Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 147 results found. Search for [ HIV ]

Results 20 to 40 of 147
www.businesstoday.in
New Delhi, March 22, 2017
Apple is cutting prices on two iPad models, but the company held back on updating its higher-end iPad Pro tablets.


www.businesstoday.in
Delhi, March 20, 2017
In spite of favourable court verdicts, top pharmaceutical companies are losing enthusiasm for fixed dose combination medicines.


www.businesstoday.in
February 24, 2017
What should then be made of statements from Cipla about its foray in Brazil and China? Is it only following others into these markets?


www.businesstoday.in
January 31, 2017
India's health ministry is likely to see a substantial increase in funding, after it warned that its programmes were short of cash and sought more than $1.2 billion in additional money, according to government officials and documents.


www.businesstoday.in
December 1, 2016
Delhi High Court on Thursday stayed a government ban on 344 drugs that it deemed lacked therapeutic efficacy, after over six months of hearing more than 300 petitions filed by drug-makers against it.


www.businesstoday.in
Delhi, October 2, 2016
We bring you tips for making a financial plan so that you can lead a stress-free life.


www.businesstoday.in
Mumbai, September 22, 2016
Market benchmark Sensex rebounded by 266 points today to close at over two-week high of 28,773.13 and the NSE Nifty went past the 8,800-mark, tracking upbeat global cues after the US Federal Reserve left rates unchanged.


www.businesstoday.in
New Delhi, August 19, 2016
\"NPPA has fixed/revised ceiling prices of 22 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013,\" the National Pharmaceutical Pricing Authority (NPPA) said in a statement.


www.businesstoday.in
New York, August 19, 2016
The second annual 'Change the World' list is topped by UK's GlaxoSmithkline, followed by Israel-based IDE Technologies and American conglomerate General Electric at the second and third positions, respectively.


www.businesstoday.in
August 3, 2016
US-based portable molecular diagnostic products firm Alere Inc has set up its first integrated manufacturing facility in Manesar, near Delhi.


www.businesstoday.in
New Delhi, August 1, 2016
\"National Pharmaceutical Pricing Authority (NPPA) has fixed/revised ceiling prices of 24 scheduled formulations of schedule-I under Drugs (Price Control) Amendment Order, 2016,\" the drug pricing regulator said in a order on its website.


www.businesstoday.in
Delhi, July 23, 2016
All that you need to know before filing a claim during overseas travel.


www.businesstoday.in
Delhi, July 23, 2016
Indian drug makers are slugging it out with Big Pharma over launch of biosimilars. Will they be able to hold their fort in this emerging space?


www.businesstoday.in
New Delhi, June 17, 2016
United Nations experts accuses Prime Minister Narendra Modi's government to repeal a law on foreign donations to charities.


www.businesstoday.in
Delhi, June 13, 2016
Business Today readers share their feedback on the magazine's coverage.


www.businesstoday.in
April 7, 2016
How we zeroed in on the country's best Insurers


www.businesstoday.in
April 7, 2016
UK-based pharma company GlaxoSmithKline and one of the oldest pharma MNC in India, has announced that it will not file for patents in the low income countries.


www.businesstoday.in
April 1, 2016
Shortages of essential drugs, mostly generic medicines whose patents have long expired, are becoming increasing frequent globally, prompting the World Health Organization (WHO) to suggest minimum prices may be needed to keep some products on the market.


www.businesstoday.in
New Delhi, April 1, 2016
As many as 103 drug formulation packs, including those used for treating bacterial infections, diabetes, high blood pressure, tuberculosis, epilepsy, Hepatitis C and HIV/AIDS, have become cheaper.


www.businesstoday.in
February 8, 2016
Considering the fact that many of these medicines are highly expensive, why should the government make it even more costly by taking such a decision?


PAGES 2 OF 8  12345